187 related articles for article (PubMed ID: 20959968)
1. Nigrostriatal denervation changes the effect of cannabinoids on subthalamic neuronal activity in rats.
Morera-Herreras T; Ruiz-Ortega JA; Linazasoro G; Ugedo L
Psychopharmacology (Berl); 2011 Mar; 214(2):379-89. PubMed ID: 20959968
[TBL] [Abstract][Full Text] [Related]
2. Regulation of subthalamic neuron activity by endocannabinoids.
Morera-Herreras T; Ruiz-Ortega JA; Taupignon A; Baufreton J; Manuel I; Rodriguez-Puertas R; Ugedo L
Synapse; 2010 Sep; 64(9):682-98. PubMed ID: 20336631
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties.
García-Arencibia M; González S; de Lago E; Ramos JA; Mechoulam R; Fernández-Ruiz J
Brain Res; 2007 Feb; 1134(1):162-70. PubMed ID: 17196181
[TBL] [Abstract][Full Text] [Related]
4. Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.
Laprairie RB; Bagher AM; Kelly ME; Dupré DJ; Denovan-Wright EM
J Biol Chem; 2014 Sep; 289(36):24845-62. PubMed ID: 25037227
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid-induced changes in respiration of brain mitochondria.
Fišar Z; Singh N; Hroudová J
Toxicol Lett; 2014 Nov; 231(1):62-71. PubMed ID: 25195527
[TBL] [Abstract][Full Text] [Related]
6. Intrasubthalamic injection of 6-hydroxydopamine induces changes in the firing rate and pattern of subthalamic nucleus neurons in the rat.
Ni Z; Bouali-Benazzouz R; Gao D; Benabid AL; Benazzouz A
Synapse; 2001 May; 40(2):145-53. PubMed ID: 11252026
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of monoamine oxidase activity by cannabinoids.
Fisar Z
Naunyn Schmiedebergs Arch Pharmacol; 2010 Jun; 381(6):563-72. PubMed ID: 20401651
[TBL] [Abstract][Full Text] [Related]
8. Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide.
Pertwee RG; Stevenson LA; Griffin G
Br J Pharmacol; 1993 Dec; 110(4):1483-90. PubMed ID: 8306090
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra.
French ED; Dillon K; Wu X
Neuroreport; 1997 Feb; 8(3):649-52. PubMed ID: 9106740
[TBL] [Abstract][Full Text] [Related]
10. Effect of microiontophoretic application of dopamine on subthalamic nucleus neuronal activity in normal rats and in rats with unilateral lesion of the nigrostriatal pathway.
Ni Z; Gao D; Bouali-Benazzouz R; Benabid AL; Benazzouz A
Eur J Neurosci; 2001 Jul; 14(2):373-81. PubMed ID: 11553287
[TBL] [Abstract][Full Text] [Related]
11. Involvement of subthalamic nucleus in the stimulatory effect of Delta(9)-tetrahydrocannabinol on dopaminergic neurons.
Morera-Herreras T; Ruiz-Ortega JA; Gómez-Urquijo S; Ugedo L
Neuroscience; 2008 Feb; 151(3):817-23. PubMed ID: 18164823
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects of cannabinoids in conscious spontaneously hypertensive rats.
Wheal AJ; Bennett T; Randall MD; Gardiner SM
Br J Pharmacol; 2007 Nov; 152(5):717-24. PubMed ID: 17700721
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study.
Pistis M; Muntoni AL; Pillolla G; Gessa GL
Eur J Neurosci; 2002 Jun; 15(11):1795-802. PubMed ID: 12081659
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol.
Romero J; Berrendero F; García-Gil L; Ramos JA; Fernández-Ruiz JJ
J Mol Neurosci; 1998 Oct; 11(2):109-19. PubMed ID: 10096037
[TBL] [Abstract][Full Text] [Related]
15. Nonclassical and endogenous cannabinoids: effects on the ordering of brain membranes.
Bloom AS; Edgemond WS; Moldvan JC
Neurochem Res; 1997 May; 22(5):563-8. PubMed ID: 9131634
[TBL] [Abstract][Full Text] [Related]
16. The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons.
Romero J; García L; Cebeira M; Zadrozny D; Fernández-Ruiz JJ; Ramos JA
Life Sci; 1995; 56(23-24):2033-40. PubMed ID: 7776829
[TBL] [Abstract][Full Text] [Related]
17. Effect of cannabinoids on platelet serotonin uptake.
Velenovská M; Fisar Z
Addict Biol; 2007 Jun; 12(2):158-66. PubMed ID: 17508987
[TBL] [Abstract][Full Text] [Related]
18. Do cannabinoids exhibit a tyramine-like effect?
Ilayan E; Feliszek M; Malinowska B; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 2013 Dec; 386(12):1041-6. PubMed ID: 23900610
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons.
Muntoni AL; Pillolla G; Melis M; Perra S; Gessa GL; Pistis M
Eur J Neurosci; 2006 May; 23(9):2385-94. PubMed ID: 16706846
[TBL] [Abstract][Full Text] [Related]
20. Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias.
Ferrer B; Asbrock N; Kathuria S; Piomelli D; Giuffrida A
Eur J Neurosci; 2003 Sep; 18(6):1607-14. PubMed ID: 14511339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]